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Epigenetic memory, in particular DNA methylation, is established
during development in differentiating cells and must be erased to
create naïve (induced) pluripotent stem cells. The ten-eleven trans-
location (TET) enzymes can catalyze the oxidation of 5-methylcytosine
(5mC) to 5-hydroxymethylcytosine (5hmC) and further oxidized
derivatives, thereby actively removing this memory. Nevertheless,
the mechanism by which the TET enzymes are regulated, and the
extent to which they can be manipulated, are poorly understood.
Here we report that retinoic acid (RA) or retinol (vitamin A) and
ascorbate (vitamin C) act as modulators of TET levels and activity.
RA or retinol enhances 5hmC production in naïve embryonic stem
cells by activation of TET2 and TET3 transcription, whereas ascor-
bate potentiates TET activity and 5hmC production through en-
hanced Fe2+ recycling, and not as a cofactor as reported previously.
We find that both ascorbate and RA or retinol promote the deriva-
tion of induced pluripotent stem cells synergistically and enhance
the erasure of epigenetic memory. This mechanistic insight has signif-
icance for the development of cell treatments for regenenerative
medicine, and enhances our understanding of how intrinsic and ex-
trinsic signals shape the epigenome.
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Epigenetic modification is a mechanism used to stably enforceand maintain gene expression patterns between different cell
types. Cytosine methylation is perhaps the most intensively
studied of these modifications. A low level of cytosine methylation
(<30% of CpG dinucleotides) is one of the few features that dis-
tinguish the most basal stem cells of the body—naïve embryonic
stem cells (nESCs)—from stem cells primed for differentiation
(1–5) or committed to somatic lineages (70–85% CpG methyl-
ation) (6, 7). Importantly, inhibitors of the DNA methylation
maintenance machinery can accelerate the reprogramming of
differentiated cells into induced pluripotent stem cells (iPSCs)
(8, 9). These features suggest that reduced DNA methylation,
either globally or at specific genomic regions, is a fundamental
property of naïve pluripotency (Fig. 1A).
A key pathway of active DNA demethylation involves the ten-
eleven translocation (TET) protein family. These Fe2+- and
oxoglutarate-dependent enzymes remove methylated cytosine
(5mC) by converting it to 5-hydroxymethylcytosine (5hmC) and
further oxidized derivatives (10–13) (Fig. 1B). TET proteins can
contribute to locus- specific demethylation in nESCs (1, 14), and
their depletion reduces the expression of pluripotency genes and
increases methylation at their promoters (12, 15). Furthermore,
forced expression of TET1 and TET2 dramatically enhances
iPSC reprogramming in a catalytically dependent manner (16–18).
Nevertheless, the molecular signals that control TET activity in
nESCs, and how they can be manipulated during reprogramming, are
poorly characterized. For example, although ascorbate (vitamin C) is
known to enhance 5hmC production in a TET-dependent manner
(19–23), the mechanism by which this occurs is unclear (Fig. 1B).
Here we report that ascorbate enhances 5hmC production and
potentiates TET catalysis, not as a cofactor as reported pre-
viously, but rather by reduction of Fe3+ to Fe2+, making it
available for participation in the TET enzyme catalytic center.
Retinol, the most common form of vitamin A in the body, is
chemically unrelated to ascorbate but similarly enhances the
production of iPSCs (24). We discovered that it also increases
5hmC production and DNA demethylation in a TET-dependent
manner. This is achieved not by an effect on enzymatic activity,
but rather through increased TET2 and TET3 expression. We
show that increased TET2 mRNA is dependent on an evolu-
tionary conserved retinoic acid (RA) receptor element (RARE)
in the first intron of its underlying gene. Finally, given the
overlapping effects of retinol and ascorbate on 5hmC production
and DNA demethylation, we tested their effects on the reprog-
ramming of primed cells to naïve pluripotency. We found syn-
ergistic effects between these two vitamins in a manner
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predicted by their interdependent effects on epigenetic memory
erasure.
Results
Ascorbate Enhances 5hmC Production Not as a Cofactor of TET, but by
Reduction of Fe3+ to Fe2+. Ascorbate has been shown to drive
DNA demethylation in cultured cells in a TET-dependent
manner (19, 21, 22, 25); however, this effect was not measured
in a genome-wide or fully quantitative fashion. We determined
cytosine modification levels in nESCs using mass spectrometry
and found that 50 μg/mL ascorbate supplementation over 72 h
decreased 5mC by almost one half (1.7-fold reduction) and in-
creased 5hmC by 2.8-fold (Fig. 1C). The absolute loss of 5mC
(0.71 pp) was 6.5-fold greater than the increase in 5hmC (0.11 pp),
implying that ascorbate drives a genuine loss of cytosine modi-
fication along with increasing 5hmC equilibrium levels.
Current biochemical studies report that ascorbate acts as a
bound cofactor of the TET proteins (19, 21–23). This hypothesis
is based largely on the observation that antioxidants other than
ascorbate have no effect on TET activity in cultured cells (19,
21–23). Moreover, several other Fe2+- and oxoglutarate-dependent
enzymes are reliant on ascorbate as a bound cofactor (26). The
classic example of this is collagen prolyl 4-hydroxylase (C-P4H),
which in the absence of substrate undergoes a partial reaction in-
volving decarboxylation of oxoglutarate and oxidation of the iron
center to the inactive Fe3+ ion. Without ascorbate, this “uncoupled”
reaction essentially destroys C-P4H activity in <1 min (27, 28) and is
thought to be responsible for many of the symptoms associated with
vitamin C deficiency.
To test whether ascorbate is required for TET function, we
measured the in vitro activity of the recombinant murine TET1
catalytic domain (TET1-CD) using an ELISA plate assay. Under
neutral conditions (pH 6.8) and 10 or 100 μM Fe2+ supple-
mentation, no stimulation of hydroxymethylation activity was
observed (Fig. 1D and Fig. S1B). This observation contrasts pre-
vious findings, including those of Yin et al. (23), who reported
that 50–500 μM ascorbate was able to enhance TET function.
One possible explanation for these discordant results could be
related to the more basic reaction conditions used by Yin et al.
(pH 8.0), in which Fe2+ is >100 times more likely to spontane-
ously oxidize to Fe3+ (29). We tested this hypothesis and found
that at pH 8.0, nearly all Fe2+ ions became oxidized within 3 min
(Fig. S1A), and ascorbate was able to rescue TET activity (Fig.
S1 B and C). In contrast, at pH 6.8, only negligible oxidation of
Fe2+ occurred after 15 min, and, accordingly, ascorbate was not
able to enhance TET catalytic activity (Fig. S1 A–C). When
TET1-CD was preincubated in the absence of methylated DNA
substrate for 30 min (conditions that promote uncoupled reac-
tions with other Fe2+- and oxoglutarate-dependent enzymes), no
loss of TET activity was seen (Fig. S1D). This demonstrates that
unlike C-P4H (27, 28), there is no obligate requirement of
ascorbate for TET activity.
To further test the hypothesis that ascorbate functions as a
bound cofactor, we inspected the structure of the TET2 catalytic
domain. In the presence of oxoglutarate and the target base,
there is insufficient space for ascorbate to also bind in the cat-
alytic pocket (Fig. S1E). Consequently, if ascorbate acts to re-
duce TET-bound iron, then at active concentrations it should
compete with substrate for a position in the catalytic pocket.
However, even with 2 mM L-ascorbate, TET1-CD activity was
not stimulated and was only slightly inhibited (Fig. S1F). As such,
we conclude that ascorbate does not act within the catalytic
pocket to reduce bound iron.
An alternative hypothesis is that ascorbate supports TET
function by converting Fe3+ (the most common form of iron in
the cell) into Fe2+, the catalytically relevant state for this class of
enzymes. To test this hypothesis, we performed in vitro 5mC
oxidation reactions of TET1-CD in the presence of Fe3+ (Fig.
1E). Consistent with the dependency of TET enzymes on Fe2+,
we observed only weak enzymatic function (∼5–12% of previous
activity); however, on addition of 1 mM ascorbate to the reaction
mixture, the oxidative capacity was reinstated (Fig. 1E). To verify
that this effect is not specific to TET1, we repeated our experi-
ments using recombinant TET2 and TET3 catalytic domain
proteins (TET2-CD and TET3-CD, respectively), and found
similar results (Fig. S1H). Along with demonstrating stereo-
isotopic insensitivity (both D and L forms were effective), our
results suggest that Fe3+ is weakly bound by TET and can be
readily replaced by Fe2+. A subsequent competition assay con-
firmed this point. A small amount of Fe2+ relative to Fe3+ (up to
100-fold less) was sufficient to retain full TET1-CD activity in
vitro (Fig. S1G).
Prompted by the foregoing observations, we analyzed whether
other common reducing agents can cause a similar effect as
ascorbate in vitro. Following supplementation with DTT, tris(2-
carboxyethyl)phosphine and reduced glutathione, 5mC oxida-
tion activity under Fe3+ conditions recovered mildly (Fig. 1E). In
contrast, hydroquinone and N-acetyl-L-cysteine showed little or
no effect. Nevertheless, different reducing agents are known
to show variable efficiencies for Fe3+ reduction (30). As such, we
preincubated the reaction mixture containing Fe3+ ions for 30 min
in the presence of a reducing agent and subsequently started the
reactions by the addition of TET1-CD. This time, we observed
robust recovery of TET1-CD activity for almost all reducing
agents used (Fig. 1E). These results further emphasize the critical
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Fig. 1. TET protein catalytic activity in vitro is rescued by the addition of
Fe2+, ascorbate, or other antioxidants. (A) Major loss of DNA methylation,
globally and at gene promoters, is associated with naïve pluripotent cells.
(B) Demethylation during reprogramming is affected by the activity of the
Fe2+-dependent TET hydroxylases, which create 5hmC and other oxidized
derivatives (5fC and 5caC). However, what regulates TET levels is largely
unknown, and the mechanism by which factors such as ascorbate affect
TET-mediated oxidation are unclear. (C) Global levels of 5mC and 5hmC (%)
in nESCs following 72 h of supplementation with 50 μg/mL ascorbate (± SD;
n = 3). (D) Kinetics of TET1-CD–mediated 5hmC production when supple-
mented with 100 μM iron (Fe2+ or Fe3+) and 1 mM ascorbate (corresponds to
172.12 μg/mL). (E, Upper) Relative activity of TET1-CD when supplemented
with 100 μM iron (Fe2+ or Fe3+) and various antioxidants. (E, Lower) The same
experiment repeated, with the antioxidant and iron mix preincubated for
30 min before the addition of TET1-CD (± SD; n = 4). NR represents reaction
conditions without added reducing agents. (F) Relative activity of TET1-CD at
various Fe2+ concentrations encompassing those seen in cellular contexts
(0.2–1.5 μM, indicated by a red box). The mean apparent dissociation constant
(Kd) for this reaction was determined to be 0.41 ± 0.05 μM (n = 2).
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role of appropriate iron levels and valency for TET activity, as
opposed to the presence of ascorbate per se.
To support this proposition, we examined the rates of reac-
tions performed at different Fe2+ concentrations (Fig. 1F), and
were able to infer an apparent dissociation constant (0.41 ±
0.05 μM). Significantly, this value falls within the reported range
of labile Fe2+ concentrations in resting erythroid and myeloid cul-
tured cells (0.2–1.5 μM) (31), suggesting that cellular labile iron
concentration can directly modulate TET function in cells.
Retinol Enhances 5hmC by Activating TET Expression.We and others
have previously reported that reprogramming of serum-grown
ESCs to naïve pluripotency causes a profound decrease in DNA
methylation levels (1–4), an effect precipitated by the “2i” sig-
naling inhibitors PD0325091 and CHIR99021. We also have
shown that at 72 h of reprogramming, there is a simultaneous
peak of 5hmC in the genome (1). To identify the molecular
mechanism underlying this increase in 5hmC, we investigated the
composition of the base medium used for growing the cells.
There are two different formulations of the defined base me-
dium used with 2i inhibition, the standard N2-B27 mixture
originally designed for supporting the growth of neural stem cells
(32) and another mixture in which the B27 supplement is without
vitamin A, referred to herein as VitA+ and VitA−, respectively.
When these two media types were used to convert serum-grown
ESCs to naïve conditions, VitA+ treated cells were found
to have greater loss of 5mC and increased 5hmC after 72 h
(Fig. 2A).
Mass spectrometry analysis of these different formulations at
working concentrations revealed that the VitA+ medium con-
tains ∼6 ng/mL of all-trans retinyl acetate (Fig. 2B), a common
form of vitamin A used in cell culture media. Retinyl acetate and
retinol show similar biological effects at equal concentrations;
however, retinol is the most common form of vitamin A in hu-
man blood. As such, we supplemented nESCs grown in VitA−
media with increasing levels of retinol up to 50 ng/mL, and found
that it resulted in a 27% increase in 5hmC and a 26% decrease in
5mC (Fig. 2C, black bars). Cosupplementation of ascorbate with
increasing retinol concentrations additively decreased 5mC and
increased 5hmC, except at high doses, where 5hmC levels be-
came saturated (Fig. S2A, gray bars).
To understand how 5hmC is increased and 5mC is decreased
by retinol treatment, we tested TET triple-knockout (TET-TKO)
ESCs under the same conditions (Fig. 2D). No retinol-dependent
decrease in 5mC was observed in these cells, indicating a re-
quirement of the original retinol effect on TET proteins and
5hmC. When we partially rescued 5hmC production in the
TET-TKO cells by forced expression of either TET1 or TET2 (the
two most abundant TETs in ESCs), we found no increase in 5hmC
upon retinol supplementation, and also no loss of 5mC (Fig. 2D
and Fig. S3A). Thus, we reasoned that retinol does not affect TET
protein stability or the efficiency of catalysis. Supporting this
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Fig. 2. Retinol increases 5hmC and reduces 5mC in nESCs. (A) Global levels
of 5mC and 5hmC (%) in serum-grown ESCs following 11 d of reprogram-
ming in 2i/LIF medium either with vitamin A (VitA+) or without vitamin A
(VitA−) (± SD; n = 3). (B) Retinyl acetate levels in VitA+/− 2i/LIF media for-
mulations (± SD; n = 3). (C) Global levels of 5mC (Upper) and 5hmC (Lower)
in nESCs supplemented with increasing levels of retinol for 72 h (black bars)
(± SD; n = 3). (D) Global levels of 5mC (Upper) and 5hmC (Lower) in 2i/LIF-
conditioned TET-TKO ESCs that were partially rescued by forced expression
of TET2 (dark gray) and were exposed to retinol for 72 h (± SD; n = 3).
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Fig. 3. Retinol enhances 5hmC in a TET2 and RA signaling-dependent
manner. (A) Relative mRNA levels from TET1-3 in nESCs supplemented with
retinol for 72 h (± SD; n = 3). (B) Relative mRNA levels from TET1-3 in nESCs
supplemented with retinol for 8 h (± SD; n = 3). (C) Relative mRNA levels
from TET1-3 in nESCs supplemented with RA (± SD; n = 3). (D) ChIP-seq of a
pan-RAR antibody in ESCs (data analyzed from ref. 34). Underneath the
major enrichment peak is an IR0-type RARE that is conserved throughout all
mammalian superorders. (E) A 104-bp deletion was created encompassing
the Tet2 RARE (green box) using a CRISPR guide RNA (orange arrow)
downstream of a protospacer adjacent motif (red text). The full deletion
coordinates are NCBI37, chr3:133197151–133197253. (F) Relative TET2 mRNA
levels in retinol-supplemented nESCs with the Tet2 RARE deleted (Tet2
ΔRARE). Wild-type (WT) control cells are included for comparison (± SD; n = 3).
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proposition, even with 30 min of preincubation, neither retinol
nor RA could rescue TET1-CD function in the presence of Fe3+
(Fig. 1D), nor could it enhance TET1-CD in the presence of
optimal Fe2+ (Fig. S3B). As such, we reasoned that retinol might
instead affect TET transcription.
To explore this idea further, we examined TET mRNA levels
in nESCs over the same range of retinol concentrations as shown
in Fig. 2. After 72 h, there was a clear dose-dependent increase in
both TET2 and TET3 mRNA in response to retinol supplemen-
tation (up to a 1.5- and 4.3-fold increase, respectively) (Fig. 3A
and Fig. S2B), indicating a direct transcriptional effect. Shorter
stimulation of the cells with retinol (8 h) activated only TET2
(Fig. 3B). Retinol is a metabolic precursor of RA, which is a
potent signaling molecule and morphogen that promotes the
anteriorization of developing vertebrate embryos (33). Direct
supplementation of cells with RA (1 mg/mL) for 72 h also increased
TET2 and TET3 expression, with only TET2 activated after 8 h (Fig.
3C). Analysis of published chromatin immunoprecipitation and se-
quencing (ChIP-seq) data using a pan-RA receptor (RAR) antibody
(34) revealed a strong peak of enrichment in ESCs 10.1 kb down-
stream of the Tet2 promoter (Fig. 3D and Fig. S4). Underneath the
apex of this peak, we discovered an inverted repeat consistent with
IR0-type RAR elements (RAREs) (34, 35). This IR0 element is
highly conserved throughout eutherian mammals, including all four
major superorders (Fig. 3D and Table S1). In contrast, we found no
RAR enrichment at Tet1, and although there was a small enrichment
peak at Tet3, we could not detect any RAREs associated with this
sequence (Fig. S4). To test whether the RARE is responsible for the
effect of retinol on TET2 expression, we deleted it using CRISPR/
Cas9 (Tet2ΔRARE; Fig. 3E). Stimulation of Tet2ΔRARE cells with
retinol did not increase TET2 expression (Fig. 3F), indicating a di-
rect role of the RARE in retinol-dependent regulation of TET2.
Retinol and Ascorbate Enhance Reprogramming of Epiblast Stem Cells
to Naïve Pluripotency. To understand the relevance of our results
from the perspective of DNA demethylation in a biological
context, we asked how retinol and ascorbate affect iPSC pro-
duction. Epiblast stem cells (EpiSCs) are derived from the em-
bryo postimplantation (E6.5), have a highly methylated genome,
and are unable to create chimeric mice on injection into a host
blastocyst (36–38). They can be reprogrammed to naïve iPSCs in
2i/LIF media (albeit relatively inefficiently) by overexpression of
at least one regulator of naïve pluripotency (36) and, in the case
of the OEC-2 EpiSC line (39), show bright and homogenous
expression of an Oct4:GFP reporter gene after 6–10 d of re-
programming (Fig. 4A).
We first compared VitA+ and VitA− reprogramming media
(i.e., with and without retinyl acetate, respectively) on KLF4-
overexpressing OEC-2 EpiSCs, and found that the latter resulted
in less than one-half the number of Oct4:GFP+ colonies after 6 d
of reprogramming and almost one-third fewer after 10 d (Fig.
4B). When we tested this effect over the same range of retinol
from Fig. 2, we found that the number of Oct4:GFP+ colonies
increased proportionally up to a concentration of 6.25 ng/mL
(Fig. 4C, black line) but that beyond this point, further increases
in retinol actually decreased the number of Oct4:GFP+ colonies,
such that at 50 ng/mL of retinol, almost no reprogrammed col-
onies were found. Combining ascorbate treatment with retinol
enhanced reprogramming considerably, as previously reported in
other systems (40, 41), but exhibited an interesting additional
effect (Fig. 4C, purple line). The dose–response curve was clearly
shifted to the left, meaning that the maximum number of Oct4:
GFP+ colonies produced resulted from a lower retinol concen-
tration when cosupplemented with ascorbate (3.13 ng/mL).
These results are consistent with the hypothesis that increased
5hmC and decreased 5mC due to retinol and ascorbate enhance
the reprogramming of EpiSCs, and that their costimulation re-
sults in increased reprogramming synergistically.
Discussion
DNA methylation erasure in the germ line and during experi-
mental reprogramming are closely linked to the acquistition of
pluripotency. TET-mediated production of 5hmC can enhance
DNA demethylation (reviewed in ref. 6); however, the mechanistic
details involved with this process and what can be done to ma-
nipulate it are much less understood. Here we show that DNA
demethylation and steady-state 5hmC levels can be enhanced in
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Fig. 4. Retinol and ascorbate enhance reprogramming of epiblast stem cells
to naïve pluripotency. (A) Experimental setup for EpiSC reprogramming
experiments. (B) Oct4:GFP+ colonies following 6–10 d of reprogramming in
VitA+/− 2i/LIF media. (Left) Representative microscopic field views at day 10
(4× magnification; the GFP channel is colored green and superimposed over
a brightfield image of the same view). (Right) Frequency of reprogrammed
colonies (± SD; n = 3). (C) Frequency of Oct4:GFP+ colonies after 6 d of
reprogramming in VitA− 2i/LIF media with supplemented retinol and
ascorbate (± SD; n = 3).
Fig. 5. Retinol and ascorbate enhance DNA demethylation, 5hmC pro-
duction, and pluripotent stem cell reprogramming by synergistic mecha-
nisms. The RARE in the first intron of Tet2 allows increased expression of
TET2 mRNA on stimulation of RA signaling (by retinol, retinyl acetate, or RA
itself) and enhanced binding of the RAR (brown enzyme). In contrast,
ascorbate increases the active iron (Fe2+, green circles) required for the TET
catalytic center by reduction from Fe3+ (red circles). Together, retinol and
ascorbate additively enhance 5hmC production, resulting in greater removal
of methylation from DNA. The enhancing effect of ascobate and retinol on
naïve pluripotent stem cell reprogramming is greater than the sum of their
individual effects.
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nESCs by various retinoid forms and ascorbate through distinct
mechanisms (Fig. 5).
We find that ascorbate supports TET activity not as an es-
sential cofactor, but rather by reduction of nonenzyme-bound
Fe3+ to Fe2+. Unlike C-P4H, which is reliant on ascorbate for its
activity, TET does not undergo uncoupled reactions that destroy
its activity in the absence of substrate (Fig. S1G). Moreover,
under conditions of sufficient Fe2+ and neutral pH, ascorbate
does not enhance TET function (Fig. 1D). When faced with
insufficient Fe2+ (and excess Fe3+), ascorbate dramatically res-
cues TET activity, but other reducing agents can do this as well,
provided that sufficient incubation time is provided (Fig. 1E).
Although these results challenge the findings reported in the
literature (19, 21–23), they are in complete agreement with the
recent finding that redox-active quinones stimulate TET activity
in cell culture through reduction of enzyme-free Fe3+ to Fe2+
(42). Taken together, these results imply that TET proteins are
inherently sensitive to labile iron concentrations in the cell, an
idea supported by the fact that the dissociation constant of Fe2+
and TET1-CD overlaps with the physiological range of labile
iron in the cell (Fig. 1F).
In contrast to ascorbate, we found that retinol and RA do not
have any effect on TET enzyme efficiency in cell culture (Fig. 2D)
or in vitro (Fig. 1E), but instead enhance DNA demethylation and
increase 5hmC by activating TET2 and TET3 expression (Fig. 3).
We also found that human nESCs grown in media with vitamin A
supplementation (i.e., retinyl acetate; Fig. 2B) have more genomic
5hmC than those grown without it (Fig. S5), supporting our
original observations in mouse nESCs (Fig. 2C) and implying that
this is a conserved regulatory effect. TET2 activation has been
previously associated with RA treatment in embryonal carcinoma
cells (43); however, the nature of this association is unknown.
Given that TET2 responds to retinol and RA stimulation within
8 h in a manner dependent on a eutherian-conserved IR0-type
RARE within its first intron (Fig. 3), we conclude that Tet2 is a
direct target of RA signaling.
When ascorbate and retinol are supplemented in combination,
RA signaling will increase TET protein levels and ascorbate will
potentiate its activity (Fig. 5). A prediction arising from this
scenario is that the combined effect of retinol and ascorbate
should be greater than the sum of their individual effects, owing
to complementary effects on shared cellular components. Indeed,
ascorbate treatment essentially “sensitizes” EpiSCs to lower levels
of retinol (Fig. 4C), which suggests that the improvement in
reprogramming by both small molecules is affecting the same
pathway, the nexus of which is 5hmC.
Our results demonstrate that intermediate levels of RA signal-
ing enhance the reprogramming of EpiSCs to naïve pluripotency
(Fig. 4). Supplemented retinol above 6.25 ng/mL suppresses
reprogramming in a dose-dependent manner, an effect that we
speculate is due to the well-described ability of RA to stimulate
differentiation. Interestingly, retinol levels in the serum of mice
(44) and humans (45) is higher than the range that we tested; thus,
adult levels of RA signaling may form one potential barrier by
which somatic cells are protected from spontaneous de-differentation.
A previous study showed that optimum levels of retinoid stimulation
are critical for the reprogramming of EpiSCs to iPSCs, and that
RA signaling strongly affects the reprogramming of mouse em-
bryonic fibroblasts (24). That study further showed that small-
molecule antagonists of RA signaling attenuate β-catenin and
activate Wnt signaling in EpiSCs, thus providing a likely mech-
anism for how RA enhances reprogramming. We suggest that in
addition to this effect, RA signaling enhances reprogramming by
directly activating TET2 expression, a known reprogramming
factor (16, 18).
In summary, our work provides mechanistic insight into how
TET proteins remove epigenetic information during reprogram-
ming to naïve pluripotency, and how this process can be manipu-
lated through the use of retinol and ascorbate. Nevertheless, the
significance of our work is not limited to the elucidation of these
fundamental processes and their application to iPSC reprogram-
ming. For example, our finding that TET activity is sensitive to
physiological changes in iron suggests that TET may represent a
conduit through which alterations in this ion are signaled to the
genome. Moreover, the observation that RA signaling enhances
TET2 expression could be relevant for the treatment of certain
cancers. TET2 is a well-described tumor suppressor that is regu-
larly mutated in a number of hematopoietic malignancies (46).
Acute promyelocytic leukemia (APL) is a form of myeloid ma-
lignancy characterized by PML-RARα translocation and sensitivity
to RA treatment, such that RA used in combination with arsenic
trioxide can provide a 5-year event-free survival rate of >90% (47,
48), a dramatic improvement for what was once considered the
deadliest form of acute leukemia. Nevertheless, a significant
number of patients are resistant to RA treatment. A recent anal-
ysis found that 4.5% of patients with APL have mutations in
TET2, and that a mutation in this and other epigenetic modifiers is
a significant indicator of poor disease outcome (49). Our work
provides a potential mechanistic explanation for RA insensitivity
in patients with APL with TET2 mutations, and if proven in fur-
ther experimentation, could affect the management of this disease.
Methods
Our methodology is described in detail in SI Methods. In brief, stem cell
culture was performed according to standard techniques as reported pre-
viously (1, 16), with modifications as described in Tables S2 and S3. Mass
spectrometry analysis of nucleosides was performed as described previously
(50). An ELISA-based plate assay was used to quantify the 5hmC produced by
a TET1 catalytic domain protein (TET1-CD) in vitro. EpiSC reprogramming
was performed as described previously (39), with modifications as outlined
in SI Methods.
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